Details for New Drug Application (NDA): 090761
✉ Email this page to a colleague
The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.
Summary for 090761
Tradename: | ATRACURIUM BESYLATE |
Applicant: | Hospira Inc |
Ingredient: | atracurium besylate |
Patents: | 0 |
Pharmacology for NDA: 090761
Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 090761
Suppliers and Packaging for NDA: 090761
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 090761 | ANDA | Hospira, Inc. | 0409-1105 | 0409-1105-02 | 10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Oct 18, 2012 | TE: | AP | RLD: | No |
Complete Access Available with Subscription